Navigation Links
QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
Date:3/31/2017

HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer. QIAGEN has acquired an exclusive worldwide license from Johns Hopkins University for detecting the AR-V7 biomarker in all sample and cell types through nucleic acid tests such as polymerase chain reaction (PCR) or next-generation sequencing (NGS). Johns Hopkins researchers have used AdnaTest technology in studies to evaluate the expression of AR-V7 messenger RNA in prostate cancer patients.

"Our AdnaTest workflow unlocks an important biomarker for clinical research to provide for the development of prostate cancer diagnostics in the future. Providing accurate insights from circulating tumor cells in a blood sample, our AR-V7 solution is a significant addition to our portfolio of non-invasive liquid biopsies for Personalized Healthcare," said Thierry Bernard, Senior Vice President and Head of QIAGEN's Molecular Diagnostics Business Area. "We are pleased to partner with the pioneering researchers at Johns Hopkins in developing this workflow. We plan to make the AdnaTest kit commercially available this year, as a Sample to Insight solution for clinical researchers."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={55C014E9-91D1-4E5E-8FF0-822B2224081A}&lang=en

Contacts: 

QIAGEN 

Investor Relations            
John Gilardi    
+49-2103-29-11711        
e-mail: ir@QIAGEN.com             
           
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826  
e-mail: pr@QIAGEN.com


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. QIAGENs QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits
4. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
5. QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft
6. QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System
7. Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
8. Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta
9. QIAGEN GeneReader NGS System to Relaunch in U.S. Market
10. QIAGENs GeneReader NGS System Streamlines Data Management for Labs
11. QIAGEN führt Flüssigbiopsie-Workflow für das GeneReader NGS-System ein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... LAKES, Fla. (PRWEB) , ... January 14, 2019 ... ... and distributing Cushion Grip, Thermoplastic Denture Adhesive, to the U.S. market. Bayer ... Bayer’s multinational product rights concerning the CUSHION GRIP brand to USpharma. Since ...
(Date:1/14/2019)... ... January 13, 2019 , ... Datalogic , a global leader ... Memor™ 10 rugged mobile computer , one of the few rugged devices validated ... of a new family of rugged Android PDA devices from Datalogic. It offers ...
(Date:1/11/2019)... ... 2019 , ... Isagenix International , known for its ... health. The global health and wellness company just launched IsaBiome™ Daily Digestive Health ... better daily digestion of meals and long-term gut health.† The products were designed ...
Breaking Medicine Technology:
(Date:1/21/2019)... ... ... imaware(TM) , an at-home testing platform for chronic illness and diseases designed by ... with Celiac Disease. The platform now includes an easy-to-use monitoring test for those who ... changes. The new monitoring test follows the company’s recent launch of its ...
(Date:1/20/2019)... , ... January 18, 2019 , ... Park Cities Pet Sitter has just announced a promotion to kick off the ... service with the company will receive three free weeks of walks during that time. ... a set schedule. A client would need to utilize a minimum of three walks per ...
(Date:1/20/2019)... PETALUMA, Calif. (PRWEB) , ... January 18, 2019 ... ... senior care experts, recently made its debut in Entrepreneur magazine’s Franchise 500, the ... is a highly sought-after honor in the franchise industry, as evidenced by the ...
(Date:1/20/2019)... ... January 19, 2019 , ... With more than 20 years ... quality and delivery of health care services to SCFHP members via medical oversight ... Services and Supports and Behavioral Health. In addition, she oversees the development and ...
(Date:1/15/2019)... MOUNTAIN VIEW, Calif. (PRWEB) , ... January 15, 2019 , ... ... is pleased to announce the opening of yet another office location for the thriving ... 94040. The new clinic is slated to open in mid-February and will offer the ...
Breaking Medicine News(10 mins):